{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:52:50Z","timestamp":1791496370195,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Economy and Competitiveness of the Spanish Government, within the project denominated SURFEYE","award":["RTC-2014-2375-1"],"award-info":[{"award-number":["RTC-2014-2375-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10792-017-0582-7","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T08:21:25Z","timestamp":1497514885000},"page":"1193-1204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops"],"prefix":"10.1007","volume":"38","author":[{"given":"Ronald Mauricio","family":"Sanchez-Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Merayo-Lloves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Riestra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Fernandez-Vega Cueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Anitua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Bego\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Muruzabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorka","family":"Orive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"582_CR1","first-page":"571","volume":"8","author":"M Sacchetti","year":"2014","unstructured":"Sacchetti M, Lambiase A (2014) Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol 8:571\u2013579","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"582_CR2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.eye.6700616","volume":"17","author":"S Bonini","year":"2003","unstructured":"Bonini S, Rama P, Olzi D, Lambiase A (2003) Neurotrophic keratitis. Eye 17(8):989\u2013995","journal-title":"Eye"},{"key":"582_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1755-3768.1989.tb07103.x","volume":"192","author":"HD Cavanagh","year":"1989","unstructured":"Cavanagh HD, Colley AM (1989) The molecular basis of neurotrophic keratitis. Acta Ophthalmol Suppl (Oxf) 192:115\u2013134","journal-title":"Acta Ophthalmol Suppl (Oxf)"},{"issue":"4","key":"582_CR4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00055735-199908000-00009","volume":"10","author":"A Lambiase","year":"1999","unstructured":"Lambiase A, Rama P, Aloe L, Bonini S (1999) Management of neurotrophic keratopathy. Curr Opin Ophthalmol 10(4):270\u2013276","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"582_CR5","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.ophtha.2006.12.014","volume":"114","author":"KC Yoon","year":"2007","unstructured":"Yoon KC, You IC, Im SK, Jeong TS, Park YG, Choi J (2007) Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology 114(9):1637\u20131642","journal-title":"Ophthalmology"},{"issue":"2","key":"582_CR6","first-page":"145","volume":"14","author":"P Versura","year":"2016","unstructured":"Versura P, Buzzi M, Giannaccare G, Terzi A, Fresina M, Velati C, Campos EC (2016) Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops. Blood Transfus 14(2):145\u2013151","journal-title":"Blood Transfus"},{"issue":"Suppl 1","key":"582_CR7","first-page":"44","volume":"12","author":"P Versura","year":"2014","unstructured":"Versura P, Buzzi M, Giannaccare G, Grillini M, Terzi A, Pagliaro P, Campos EC (2014) Cord blood serum-based eye drops: the impact of donor haematological and obstetric factors on the variability of epidermal growth factor levels. Blood Transfus 12(Suppl 1):44\u201350","journal-title":"Blood Transfus"},{"issue":"2","key":"582_CR8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/ICO.0b013e3181eadb67","volume":"30","author":"EP Shen","year":"2011","unstructured":"Shen EP, Hu F-R, Lo S-C, Chen Y-M, Sun Y-C, Lin C-T, Chen W-L (2011) Comparison of corneal epitheliotrophic capacity among different human blood-derived preparations. Cornea 30(2):208\u2013214","journal-title":"Cornea"},{"issue":"10","key":"582_CR9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/ICO.0b013e3181a2a7f6","volume":"28","author":"BH Jeng","year":"2009","unstructured":"Jeng BH, Dupps WJ (2009) Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Cornea 28(10):1104\u20131108","journal-title":"Cornea"},{"issue":"6","key":"582_CR10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ophtha.2003.10.019","volume":"111","author":"Y Matsumoto","year":"2004","unstructured":"Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, Tsubota K (2004) Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111(6):1115\u20131120","journal-title":"Ophthalmology"},{"issue":"3","key":"582_CR11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jbm.a.35244","volume":"103","author":"E Anitua","year":"2015","unstructured":"Anitua E, Zalduendo MM, Prado R, Alkhraisat MH, Orive G (2015) Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion. J Biomed Mater Res A 103(3):1011\u20131020","journal-title":"J Biomed Mater Res A"},{"issue":"3","key":"582_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0121713","volume":"10","author":"E Anitua","year":"2015","unstructured":"Anitua E, Zalduendo M, Troya M, Padilla S, Orive G (2015) Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties. PLoS ONE 10(3):1\u201319","journal-title":"PLoS ONE"},{"issue":"9","key":"582_CR13","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1167\/iovs.11-7302","volume":"52","author":"E Anitua","year":"2011","unstructured":"Anitua E, Sanchez M, Merayo-Lloves J, De la Fuente M, Muruzabal F, Orive G (2011) Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation. Invest Ophthalmol Vis Sci 52(9):6066\u20136073","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"582_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.exer.2013.07.007","volume":"115","author":"E Anitua","year":"2013","unstructured":"Anitua E, Muruzabal F, Alcalde I, Merayo-Lloves J, Orive G (2013) Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. Exp Eye Res 115:153\u2013161","journal-title":"Exp Eye Res"},{"key":"582_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exer.2013.12.005","volume":"119","author":"E Anitua","year":"2014","unstructured":"Anitua E, Muruzabal F, De la Fuente M, Merayo-Lloves J, Orive G (2014) Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop. Exp Eye Res 119:27\u201334","journal-title":"Exp Eye Res"},{"issue":"10","key":"582_CR16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/ICO.0b013e31829f7088","volume":"32","author":"E Anitua","year":"2013","unstructured":"Anitua E, Muruzabal F, Pino A, Merayo-Lloves J, Orive G (2013) Biological stability of plasma rich in growth factors eye drops after storage of 3 months. Cornea 32(10):1380\u20131386","journal-title":"Cornea"},{"key":"582_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2015.01.029","volume":"202","author":"E Anitua","year":"2015","unstructured":"Anitua E, Pelacho B, Prado R, Aguirre JJ, S\u00e1nchez M, Padilla S, Aranguren XL, Abizanda G, Collantes M, Hernandez M, Perez-Ruiz A, Pe\u00f1uelas I, Orive G, Prosper F (2015) Infiltration of plasma rich in growth factors enhances in vivo angiogenesis and improves reperfusion and tissue remodeling after severe hind limb ischemia. J Control Release 202:31\u201339","journal-title":"J Control Release"},{"issue":"3","key":"582_CR18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jcp.22274","volume":"225","author":"P Bendinelli","year":"2010","unstructured":"Bendinelli P, Matteucci E, Dogliotti G, Corsi MM, Banfi G, Maroni P, Desiderio MA (2010) Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kB inhibition via HGF. J Cell Physiol 225(3):757\u2013766","journal-title":"J Cell Physiol"},{"key":"582_CR19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2230.2011.04303.x","volume":"37","author":"E Anitua","year":"2012","unstructured":"Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G (2012) Antibacterial effect of plasma rich in growth factors (PRGF\u00ae-Endoret\u00ae) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol 37:652\u2013657","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"582_CR20","doi-asserted-by":"crossref","first-page":"e107813","DOI":"10.1371\/journal.pone.0107813","volume":"9","author":"L Drago","year":"2014","unstructured":"Drago L, Bortolin M, Vassena C, Roman\u00f2 CL, Taschieri S, Del Fabbro M (2014) Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study. PLoS ONE 9(9):e107813","journal-title":"PLoS ONE"},{"issue":"9118","key":"582_CR21","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(98)24024-4","volume":"351","author":"TI Chikama","year":"1998","unstructured":"Chikama TI, Fukuda K, Morishige N, Nishida T (1998) Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet 351(9118):1783\u20131784","journal-title":"Lancet"},{"key":"582_CR22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0161-6420(00)00163-9","volume":"107","author":"S Bonini","year":"2000","unstructured":"Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L (2000) Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107:1347\u20131351","journal-title":"Ophthalmology"},{"issue":"6","key":"582_CR23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/WCO.0b013e32834c208d","volume":"24","author":"LI Benowitz","year":"2011","unstructured":"Benowitz LI, Popovich PG (2011) Inflammation and axon regeneration. Curr Opin Neurol 24(6):577\u2013583","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"582_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.survophthal.2013.09.002","volume":"59","author":"BS Shaheen","year":"2014","unstructured":"Shaheen BS, Bakir M, Jain S (2014) Corneal nerves in health and disease. Surv Ophthalmol 59(3):263\u2013285","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"582_CR25","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","volume":"88","author":"G Geerling","year":"2004","unstructured":"Geerling G, Maclennan S, Hartwing D (2004) Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 88(11):1467\u20131474","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"582_CR26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jor.20278","volume":"25","author":"LV Schnabel","year":"2007","unstructured":"Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, Fortier LA (2007) Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 25(2):230\u2013240","journal-title":"J Orthop Res"},{"issue":"4","key":"582_CR27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","volume":"26","author":"K-C Yoon","year":"2007","unstructured":"Yoon K-C, Jeong I-Y, Park Y-G, Yang S-Y (2007) Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 26(4):431\u2013437","journal-title":"Cornea"},{"issue":"9","key":"582_CR28","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1167\/iovs.11-7340","volume":"53","author":"V Freire","year":"2012","unstructured":"Freire V, Andollo N, Etxebarria J, Dur\u00e1n JA, Morales M-C (2012) In vitro effects of three blood derivatives on human corneal epithelial cells. Invest Ophthalmol Vis Sci 53(9):5571\u20135578","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"582_CR29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.tibtech.2015.07.002","volume":"33","author":"E Anitua","year":"2015","unstructured":"Anitua E, Prado R, Orive G (2015) Closing regulatory gaps: new ground rules for platelet-rich plasma. Trends Biotechnol 33(9):492\u2013495","journal-title":"Trends Biotechnol"},{"key":"582_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exer.2013.12.005","volume":"119","author":"E Anitua","year":"2014","unstructured":"Anitua E, Muruzabal F, De la Fuente M, Merayo-Lloves J, Orive G (2014) Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop. Exp Eye Res 119:27\u201334","journal-title":"Exp Eye Res"},{"key":"582_CR31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.exer.2015.02.016","volume":"135","author":"E Anitua","year":"2015","unstructured":"Anitua E, de la Fuente M, Muruzabal F, Riestra A, Merayo-Lloves J, Orive G (2015) Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts. Exp Eye Res 135:118\u2013126","journal-title":"Exp Eye Res"},{"key":"582_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aos.12710","volume":"93","author":"E Anitua","year":"2015","unstructured":"Anitua E, Muruzabal F, Tayebba A, Riestra A, Perez VL, Merayo-Lloves J, Orive G (2015) Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Acta Ophthalmol 93:1\u201310","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"582_CR33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3109\/02713683.2015.1104362","volume":"41","author":"E Anitua","year":"2016","unstructured":"Anitua E, Muruzabal F, de la Fuente M, Merayo J, Duran J, Orive G (2016) Plasma rich in growth factors for the treatment of ocular surface diseases. Curr Eye Res 41(7):875\u2013882","journal-title":"Curr Eye Res"},{"issue":"2","key":"582_CR34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000444496","volume":"56","author":"J Merayo-Lloves","year":"2016","unstructured":"Merayo-Lloves J, Sanchez-Avila RM, Riestra AC, Anitua E, Begona L, Orive G, Fernandez-Vega L (2016) Safety and efficacy of autologous plasma rich in growth factors eye drops for the treatment of evaporative dry eye. Ophthalmic Res 56(2):68\u201373","journal-title":"Ophthalmic Res"},{"issue":"2","key":"582_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000439280","volume":"55","author":"J Merayo-Lloves","year":"2015","unstructured":"Merayo-Lloves J, Sanchez RM, Riestra AC, Anitua E, Begona L, Orive G, Fernandez-Vega L (2015) Autologous plasma rich in growth factors eyedrops in refractory cases of ocular surface disorders. Ophthalmic Res 55(2):53\u201361","journal-title":"Ophthalmic Res"},{"issue":"6","key":"582_CR36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10384-012-0175-y","volume":"56","author":"KM Kim","year":"2012","unstructured":"Kim KM, Shin Y-T, Kim HK (2012) Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis. Jpn J Ophthalmol 56(6):544\u2013550","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"582_CR37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000354380","volume":"231","author":"F Semeraro","year":"2014","unstructured":"Semeraro F, Forbice E, Romano V, Angi M, Romano MR, Filippelli ME, Di Iorio R, Costagliola C (2014) Neurotrophic keratitis. Ophthalmologica 231(4):191\u2013197","journal-title":"Ophthalmologica"},{"issue":"13","key":"582_CR38","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1167\/iovs.12-10476","volume":"53","author":"A Aifa","year":"2012","unstructured":"Aifa A, Gueudry J, Portmann A, Delcampe A, Muraine M (2012) Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. Invest Ophthalmol Vis Sci 53(13):8181\u20138185","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"582_CR39","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jfo.2013.01.012","volume":"36","author":"F Brignole-Baudouin","year":"2013","unstructured":"Brignole-Baudouin F, Warnet JM, Barritault D, Baudouin C (2013) RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies. J Fr Ophtalmol 36(9):740\u2013747","journal-title":"J Fr Ophtalmol"},{"issue":"8","key":"582_CR40","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/ICO.0000000000000169","volume":"33","author":"GD Kymionis","year":"2014","unstructured":"Kymionis GD, Liakopoulos DA, Grentzelos MA, Diakonis VF, Klados NE, Tsoulnaras KI, Tsilimbaris MK, Pallikaris IG (2014) Combined topical application of a regenerative agent with a bandage contact lens for the treatment of persistent epithelial defects. Cornea 33(8):868\u2013872","journal-title":"Cornea"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-017-0582-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0582-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0582-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T19:50:27Z","timestamp":1719258627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-017-0582-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1007\/s10792-017-0582-7","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]}}}